These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3962179)

  • 21. LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration.
    Lukashevich IS; Rodas JD; Tikhonov II; Zapata JC; Yang Y; Djavani M; Salvato MS
    Arch Virol; 2004 Dec; 149(12):2319-36. PubMed ID: 15338320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral superinfection in cells carrying an arenavirus and/or a togavirus.
    Nguyen-hong-Diet ; Libíková H
    Acta Virol; 1978 Nov; 22(6):477-84. PubMed ID: 35946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunopathological basis of lymphocytic choriomeningitis virus-induced chorioretinitis and keratitis.
    Zinkernagel MS; Bolinger B; Krebs P; Onder L; Miller S; Ludewig B
    J Virol; 2009 Jan; 83(1):159-66. PubMed ID: 18945766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental animals and in vitro systems in the study of lymphocytic choriomeningitis virus.
    Hotchin J
    Bull World Health Organ; 1977; 55(5):599-603. PubMed ID: 338190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological relationship of the Tacaribe complex of viruses to lymphocytic choriomeningitis virus.
    Rowe WP; Pugh WE; Webb PA; Peters CJ
    J Virol; 1970 Mar; 5(3):289-92. PubMed ID: 4985595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of lymphocytic choriomeningitis virus--induced growth hormone deficiency syndrome by disease-negative virus variants.
    Teng MN; Oldstone MB; de la Torre JC
    Virology; 1996 Sep; 223(1):113-9. PubMed ID: 8806545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection.
    Oldstone MB; Buchmeier MJ; Doyle MV; Tishon A
    J Immunol; 1980 Feb; 124(2):831-8. PubMed ID: 6444319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein.
    Rodriguez-Carreno MP; Nelson MS; Botten J; Smith-Nixon K; Buchmeier MJ; Whitton JL
    Virology; 2005 Apr; 335(1):87-98. PubMed ID: 15823608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An interfering activity against lymphocytic choriomeningitis virus replication associated with enhanced mutagenesis.
    Martín V; Abia D; Domingo E; Grande-Pérez A
    J Gen Virol; 2010 Apr; 91(Pt 4):990-1003. PubMed ID: 20007356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice.
    Thomsen AR; Volkert M; Marker O
    Immunology; 1985 Jun; 55(2):213-23. PubMed ID: 4007926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD164 is a host factor for lymphocytic choriomeningitis virus entry.
    Bakkers MJG; Moon-Walker A; Herlo R; Brusic V; Stubbs SH; Hastie KM; Saphire EO; Kirchhausen TL; Whelan SPJ
    Proc Natl Acad Sci U S A; 2022 Mar; 119(10):e2119676119. PubMed ID: 35235462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
    Walker CM; Paetkau V; Rawls WE; Rosenthal KL
    J Immunol; 1985 Aug; 135(2):1401-7. PubMed ID: 2989365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. V. Recognition is restricted to gene products encoded by the viral S RNA segment.
    Riviere Y; Southern PJ; Ahmed R; Oldstone MB
    J Immunol; 1986 Jan; 136(1):304-7. PubMed ID: 3484391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of defective lymphocytic choriomeningitis virus.
    Welsh RM; O'Connell CM; Pfau CJ
    J Gen Virol; 1972 Dec; 17(3):355-9. PubMed ID: 4650728
    [No Abstract]   [Full Text] [Related]  

  • 35. Arenavirus inactivation on contact with N-substituted isatin beta-thiosemicarbazones and certain cations.
    Logan JC; Fox MP; Morgan JH; Makohon AM; Pfau CJ
    J Gen Virol; 1975 Sep; 28(3):271-83. PubMed ID: 809544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plaque size heterogeneity: a genetic trait of lymphocytic choriomeningitis virus.
    Pulkkinen AJ; Pfau CJ
    Appl Microbiol; 1970 Jul; 20(1):123-8. PubMed ID: 4195608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arenavirus diversity and evolution: quasispecies in vivo.
    Sevilla N; de la Torre JC
    Curr Top Microbiol Immunol; 2006; 299():315-35. PubMed ID: 16568904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel arenavirus infection in humans, United States.
    Milazzo ML; Campbell GL; Fulhorst CF
    Emerg Infect Dis; 2011 Aug; 17(8):1417-20. PubMed ID: 21801618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of Junin and Tacaribe viruses during mixed infections.
    Damonte EB; Coto CE
    Intervirology; 1985; 23(1):1-7. PubMed ID: 2982755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The requirement of reactive oxygen intermediates for lymphocytic choriomeningitis virus binding and growth.
    Michalek RD; Pellom ST; Holbrook BC; Grayson JM
    Virology; 2008 Sep; 379(2):205-12. PubMed ID: 18691729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.